Skip to content

MoonLake Immunotherapeutics MLTX Defined Benefit Pension Plan Liabilities (Non-Current)

Defined Benefit Pension Plan Liabilities (Non-Current) at other companies

CSW Industrials, Inc. logo
CSW Industrials, Inc.CSW
$1.04M-4.0%
Sonoco Products logo
Sonoco ProductsSON
$176.37M-3.8%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$38.5M+23.0%
Belden logo
BeldenBDC
$62.77M-3.8%
Valvoline logo
ValvolineVVV
$180M+5.0%
Brink's, Inc. logo
Brink's, Inc.BCO
$148.9M+16.1%

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.49B-45.9%
Enterprise value$1.29B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's defined benefit pension plan liabilities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's defined benefit pension plan liabilities (non-current)?
MoonLake Immunotherapeutics (MLTX) reported defined benefit pension plan liabilities (non-current) of $353K in Q1 2026.
How has MoonLake Immunotherapeutics's defined benefit pension plan liabilities (non-current) changed year-over-year?
MoonLake Immunotherapeutics's defined benefit pension plan liabilities (non-current) decreased by 34.1% year-over-year, from $536K to $353K.
What is the long-term trend for MoonLake Immunotherapeutics's defined benefit pension plan liabilities (non-current)?
Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's defined benefit pension plan liabilities (non-current) has grown at a -100.0% compound annual growth rate (CAGR), from $239.86K to $0.
What does defined benefit pension plan liabilities (non-current) mean?
This represents the long-term shortfall between the projected benefit obligations of a company's pension plans and the fair value of the plan assets. It reflects the company's long-term commitment to provide retirement benefits to employees. A significant liability indicates a potential future cash requirement to fund the pension plan.